BRISBANE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...
Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type ...
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released a new guideline outlining the steps involved for EU stakeholders, including national competent authorities, ...
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines ...
The European Medicines Agency (EMA) has begun the first real-world evidence (RWE) studies under its DARWIN EU initiative, kicking off three projects at the start of the “rapid ramp-up” of a program ...
Real-world evidence (RWE) has emerged as a vital complement to traditional randomised controlled trials by capturing the effectiveness and safety of interventions in routine clinical practice. Drawing ...
Investigator-sponsored study, conducted at the Moffitt Cancer Center, demonstrates safety and efficacy consistent with the Phase 3 IMerge trial in a broader patient population Additional presentations ...
Axena Health, Inc., a women's health company redefining the standard of care for pelvic health through clinically proven, non-invasive treatments, today announced the publication of a new real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results